Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis (Q46889094)

26 December 2017

title

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis (English)

1 reference

26 December 2017

0 references

9

1 reference

26 December 2017

Antonio Uccelli

Antonio Uccelli

11

0 references

Alastair Compston

17

Alastair Compston

1 reference

26 December 2017

15

Jonathan L Haines

1 reference

26 December 2017

12

Giovanni Savettieri

1 reference

26 December 2017

Glenys J. Thomson

5

Glenys Thomson

1 reference

26 December 2017

Lisa F Barcellos

1

Lisa F Barcellos

1 reference

26 December 2017

Jorge R. Oksenberg

19

Jorge R Oksenberg

1 reference

26 December 2017

Stephen L. Hauser

18

Stephen L Hauser

1 reference

26 December 2017

Sergio E Baranzini

4

Sergio E Baranzini

1 reference

26 December 2017

Stephen Sawcer

2

Stephen Sawcer

1 reference

26 December 2017

Margaret A. Pericak-Vance

16

Margaret A Pericak-Vance

1 reference

26 December 2017

Farren Briggs

6

Farren Briggs

1 reference

26 December 2017

Ann B Begovich

8

Ann B Begovich

1 reference

26 December 2017

Xavier Montalban

10

Xavier Montalban

1 reference

26 December 2017

author name string

Patricia P Ramsay

3

1 reference

26 December 2017

Bruce C A Cree

7

1 reference

26 December 2017

Robin R Lincoln

13

1 reference

26 December 2017

Carolyn DeLoa

14

1 reference

26 December 2017

publication date

11 August 2006

1 reference

26 December 2017

published in

Human Molecular Genetics

1 reference

26 December 2017

volume

15

1 reference

26 December 2017

page(s)

2813-2824

1 reference

26 December 2017

issue

18

1 reference

26 December 2017

Multiple sclerosis genetics: leaving no stone unturned

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

A high-density screen for linkage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Multiple sclerosis in the tropics: genetic association to STR's loci spanning the HLA and TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Polymorphisms in the gene encoding thymus-specific serine protease in the extended HLA complex: a potential candidate gene for autoimmune and HLA-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

The HLA locus and multiple sclerosis in Sicily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

HLA-DR and -DQ associations with multiple sclerosis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

HLA associations with multiple sclerosis in the Canary Islands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Modes of action of HLA-DR susceptibility specificities in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA‐DR locus in the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Ankylosing spondylitis and HL-A 27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

An integrated haplotype map of the human major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Identifying disease modifying genes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Current approved options for treating patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

HLA typing in the United Kingdom multiple sclerosis genome screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

PedCheck: a program for identification of genotype incompatibilities in linkage analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

A test for linkage and association in general pedigrees: the pedigree disequilibrium test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Correcting for a potential bias in the pedigree disequilibrium test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Genotype‐based association test for general pedigrees: The genotype‐PDT

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDL223

21 January 2018

Identifiers

DOI

10.1093/HMG/DDL223

1 reference

26 December 2017

PubMed ID

16905561

1 reference

26 December 2017